Adult Immunization Trends and the Role of Vaccine Recommendations
Last Updated03/05/2026
Recent changes to recommendations for adult pneumococcal disease and RSV vaccines have created an important opportunity to assess how expanded vaccine recommendations translate into real-world vaccination practices. This webinar highlighted IQVIA data on adult vaccination trends, offering timely evidence of how vaccine recommendations can drive uptake.
Panelists explored the implications of routine, risk-based, and shared clinical decision-making vaccine recommendations for providers, patients, and public health systems. The conversation focused on how clarity in recommendations affects provider confidence and patient access, and what lessons recent ACIP decisions offer for the future of adult immunization policy.
Panelists included:
Nandini Selvam, PhD, MPH, President of Government Solutions, IQVIA
Robert H. Hopkins, Jr., MD, Medical Director, National Foundation for Infectious Diseases
Moderator:Lindsay Clarke, COO and Senior Vice President of Health Education, Alliance for Aging Research
Infectious Respiratory Disease Immunization Timeline: Children and Adolescents (Ages 6-17)
Immunization is the best protection against many infectious respiratory illnesses. Vaccines strengthen our immune defenses and reduce the severity and spread of disease.
Last Updated12/23/2025
Infectious Respiratory Disease Immunization Timeline: Children and Adolescents (Ages 6-17)
Immunization is the best protection against many infectious respiratory illnesses. Vaccines strengthen our immune defenses and reduce the severity and spread of disease.
Immunization is the best protection against many infectious respiratory illnesses. Vaccines strengthen our immune defenses and reduce the severity and spread of disease.
Infectious Respiratory Disease Immunization Timeline: Vaccine Considerations During Pregnancy
Immunization is the best protection against many infectious respiratory illnesses. Vaccines strengthen our immune defenses and reduce the severity and spread of disease.
Last Updated12/23/2025
Infectious Respiratory Disease Immunization Timeline: Vaccine Considerations During Pregancy
Infectious Respiratory Disease Immunization Timeline: Vaccine Considerations for Adults with Increased Risk
Immunization is the best protection against many infectious respiratory illnesses. Vaccines strengthen our immune defenses and reduce the severity and spread of disease.
Last Updated12/23/2025
Infectious Respiratory Disease Immunization Timeline: Vaccine Considerations for Adults with Increased Risk
Infectious Respiratory Disease Immunization Timeline: Babies and Young Children (Ages 2 Months-6 Years)
Immunization is the best protection against many infectious respiratory illnesses. Vaccines strengthen our immune defenses and reduce the severity and spread of disease.
Last Updated12/23/2025
Infectious Respiratory Disease Immunization Timeline: Babies and Young Children (Ages 2 Months-6 Years)
Immunization is the best protection against many infectious respiratory illnesses. Learn more about the timelines for vaccination against infectious respiratory diseases for different groups of individuals.
For older adults, RSV can be very serious and causes hospitalizations and death each year. Vaccines are available to help protect against RSV and the CDC recommends vaccination for people who are at increased risk for severe RSV.
Supporting Equitable Access to Respiratory Vaccines: Best Practices and Implementation of Risk-Based Recommendations
Last Updated10/15/2024
Risk-based vaccine recommendations are an important mechanism by which public health authorities provide guidance, encourage vaccination, and reach vulnerable populations. That said, implementation of risk-based recommendations can prove challenging.
As we navigate this year’s respiratory illness season, Champions for Vaccine Education, Equity and Progress (CVEEP) held a discussion focused on best practices to support equitable access to respiratory vaccines, which will include an overview of CDC’s Advisory Committee on Immunization Practices (ACIP) recommendations for respiratory vaccines, and considerations specific to risk-based recommendations. Featuring insights from leading public health experts, clinicians, and government officials, the event explored what is working, where there might be barriers to implementation and gaps in communication and, how the public health community can work together to ensure all individuals are able to receive the vaccines they need.
Panelists included:
Karyne Jones, President and CEO of the National Caucus and Center on Black Aging and convening member of CVEEP
Dr. Reed Tuckson, Co-Founder of the Black Coalition Against COVID and Co-Founder of the Coalition For Trust in Health & Science
Dr. Evelyn Twentyman, Senior Advisor for Vaccine Strategy, National Center for Immunization and Respiratory Diseases, CDC
The discussion was moderated by Amy Pisani, CEO of Vaccinate Your Family.
